Andrew Perry serves as Executive at G1 Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Andrew Perry has executed 14 insider transactions totaling $55.4K, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 18, 2024 involved transacting 14,232 shares valued at $0.
Andrew Perry currently holds 14,232 shares of G1 Therapeutics, Inc. (GTHX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew Perry has been a net seller of GTHX stock. They have purchased $0 and sold $55.4K worth of shares.
Andrew Perry's most recent insider trade was on Sep 18, 2024, when they sold 14,232 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Sep 18, 2024 | GTHX | $0 | Award | 16,100 | $N/A | Discretionary |
| Jul 5, 2024 | GTHX | $3.4K | Sale | 1,337 | $2.51 | Discretionary |
| Jul 1, 2024 | GTHX | $0 | Award | 35,000 | $N/A | Discretionary |
| May 13, 2024 | GTHX | $39.0K | Sale | 8,151 | $4.79 | Discretionary |
| Jan 3, 2024 | GTHX | $1.2K | Sale | 379 | $3.12 | Discretionary |
| Jan 3, 2024 | GTHX | $6.3K | Sale | 2,034 | $3.12 | Discretionary |
| Jan 3, 2024 | GTHX | $0 | Award | 33,570 | $N/A | Discretionary |
| Jul 5, 2023 | GTHX | $870 | Sale | 355 | $2.45 | Planned |
| May 10, 2023 | GTHX | $0 | Award | 35,000 | $N/A | Discretionary |
| Jan 4, 2023 | GTHX | $4.6K | Sale | 820 | $5.58 | Discretionary |
| Jan 3, 2023 | GTHX | $0 | Award | 16,100 | $N/A | Discretionary |
| Jan 3, 2022 | GTHX | $0 | Award | 6,000 | $N/A | Discretionary |